Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
Source: SeekingAlpha
2026-03-06 13:44:14 ET
More on IQVIA, Medpace
- IQVIA Holdings: Still Exceeding Expectations As A Stealth Compounder
- IQVIA Holdings Inc. (IQV) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript
- Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript
- Charles River announces divestitures, updates guidance
- Medpace outlines 2026 revenue growth of up to 12.8% amid backlog normalization and metabolic trial shifts
Read the full article on Seeking Alpha
For further details see:
Medpace, IQVIA upgraded at Barclays; says AI concerns are overdone
Medpace Holdings Inc.
NASDAQ: MEDP
MEDP Trading
1.44% G/L:
$478.19 Last:
107,603 Volume:
$466.70 Open:
MEDP Latest News
February 23, 2026 12:10:00 am
Ongoing Investigation: Medpace Holdings, Inc. (MEDP) May Have Misled Shareholders - Levi & Korsinsky Investigates
February 18, 2026 09:00:00 am
Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility
February 16, 2026 01:50:00 pm
Why Big Stock Swings Like Medpace's 55% Jump Usually Have Clear Causes--Not Market Madness
MEDP Stock Data
$12,487,114,097
22,450,074
3.25%
359
N/A
Biotechnology & Life Sciences
Healthcare
US
Cincinnati
